
Manufacturing Operations Shift Lead
JR000015990 Manufacturing Operations Shift Lead (Open)
College Park, Dublin - IRL006
The Manufacturing Operations Lead is responsible for providing support and leadership to the
Manufacturing Operations Shift Team in the College Park Manufacturing Facility (CPMF) to
manufacture to the required safety, quality, and schedule and cost requirements to meet the
business needs.
You will work in partnership with Warehouse, Quality, Engineering and EHS to meet the CPMF
objectives. The role will include but not be limited to executing manufacturing activities,
building upon and improving existing process design to optimise process, facility and
equipment use while conforming to SOPs and cGMP requirements.
Roles and Responsibilities:
-Ensure timely completion of plant operations, safe operations, attention to detail, and good
documentation skills. Directly oversees and participates in daily cGMP operations in a cGMP
environment.
expected behaviours
and corrective action follow-up to ensure closure.
change controls, and validation protocols/reports.
and to generate policies, etc.
manufacturing and material management
release of materials to meet production needs.
-Acts as designee / point of contact for Operations Manager when required.
Acts as senior person on site during out of normal hours activity
At Keenova, we believe that no one should be alone in their pursuit of better health. This purpose drives us as we pair quality therapeutics with human support—showing up in big moments and small to help patients find comfort and confidence.
We bring deep expertise and resolve to every therapeutic area we serve, including immunology, urology, men’s health, orthopedics, critical care, and pediatric endocrinology. We work with patients, care partners, and physicians to help them navigate healthcare system complexity and access therapies that make a meaningful difference.
We are Keenova—keen to solve, keen to serve. Learn more at www.keenova.com.

Mallinckrodt Pharmaceuticals combined with Endo in 2025 to better serve customers and improve outcomes for the patients we support.
From this union, we established two focused, standalone companies:
– Keenova Therapeutics, a branded therapeutics business
– Par Health, a generics and sterile injectables business
To learn more, follow Keenova and Par Health on LinkedIn and visit keenova.com and parhealth.com.